These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
522 related items for PubMed ID: 2931247
1. A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levels. Kuhl H, Gahn G, Romberg G, März W, Taubert HD. Contraception; 1985 Jun; 31(6):583-93. PubMed ID: 2931247 [Abstract] [Full Text] [Related]
2. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel. Gaspard UJ, Romus MA, Gillain D, Duvivier J, Demey-Ponsart E, Franchimont P. Contraception; 1983 Jun; 27(6):577-90. PubMed ID: 6225622 [Abstract] [Full Text] [Related]
3. Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel. Gaspard UJ, Dubois M, Gillain D, Franchimont P, Duvivier J. Contraception; 1984 Apr; 29(4):305-18. PubMed ID: 6430638 [Abstract] [Full Text] [Related]
4. Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive. London RS, Chapdelaine A, Upmalis D, Olson W, Smith J. Acta Obstet Gynecol Scand Suppl; 1992 Apr; 156():9-14. PubMed ID: 1324557 [Abstract] [Full Text] [Related]
5. A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives. Aden U, Jung-Hoffmann C, Kuhl H. Contraception; 1998 Aug; 58(2):75-81. PubMed ID: 9773261 [Abstract] [Full Text] [Related]
6. Pituitary and ovarian function in women receiving hormonal contraception. Cohen BL, Katz M. Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456 [Abstract] [Full Text] [Related]
7. A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic serum parameters: II. Effects upon thyroid function, gastrin, STH, and glucose tolerance. Kuhl H, Gahn G, Romberg G, Althoff PH, Taubert HD. Contraception; 1985 Jul; 32(1):97-107. PubMed ID: 2932299 [Abstract] [Full Text] [Related]
8. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel. Song S, Chen JK, Yang PJ, He ML, Li LM, Fan BC, Rekers H, Fotherby K. Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580 [Abstract] [Full Text] [Related]
9. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity. Rossmanith WG, Steffens D, Schramm G. Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028 [Abstract] [Full Text] [Related]
10. The mechanism of action of a new low-dosed combined oral contraceptive. Dericks-Tan JS, Schneider K, Taubert HD. Arch Gynecol; 1980 Jul; 229(2):107-14. PubMed ID: 6768343 [Abstract] [Full Text] [Related]
11. Influence of oral contraceptives on integrated secretion of gonadotropins. Dericks-Tan JS, Gudacker V, Taubert HD. Contraception; 1992 Oct; 46(4):369-77. PubMed ID: 1486775 [Abstract] [Full Text] [Related]
12. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel. Gaspard UJ, Buret J, Gillain D, Romus MA, Lambotte R. Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546 [Abstract] [Full Text] [Related]
13. Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives. van Heusden AM, Fauser BC. Contraception; 1999 Apr; 59(4):237-43. PubMed ID: 10457868 [Abstract] [Full Text] [Related]
14. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol. Carlström K, Lunell NO, Zador G. Gynecol Obstet Invest; 1978 Apr; 9(6):304-11. PubMed ID: 754992 [Abstract] [Full Text] [Related]
15. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel. Lemay A, Dewailly SD, Grenier R, Huard J. J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494 [Abstract] [Full Text] [Related]
16. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis. Smith SK, Kirkman RJ, Arce BB, McNeilly AS, Loudon NB, Baird DT. Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162 [Abstract] [Full Text] [Related]
17. Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination. Cullberg G, Samsioe G, Andersen RF, Bredesgaard P, Andersen NB, Ernerot H, Fanøe E, Fylling P, Haack-Sørensen PE, Klottrup P, Pedersen JH, Sandager T. Contraception; 1982 Sep; 26(3):229-43. PubMed ID: 6217028 [Abstract] [Full Text] [Related]
18. Changes in serum apo-lipoprotein AI and sex-hormone-binding globulin levels after treatment with two different progestins administered alone and in combination with ethinyl estradiol. Crona N, Silfverstolpe G, Samsioe G. Contraception; 1984 Mar; 29(3):261-70. PubMed ID: 6234148 [Abstract] [Full Text] [Related]